International Stem Cell ISCO
OTC ISCO
$0.30 -0.01 (-3.23%)
At close: Oct 1, 2026 · 4:00 PM EDT

International Stem Cell (ISCO) Interest & Investment Income (2010)

Updated

International Stem Cell (ISCO) reported Interest & Investment Income of $1,000 for FY2011, down 96.4% from $28,000 in FY2010.

Analysis

International Stem Cell (ISCO) Interest & Investment Income (2010) Analysis & Trends

  • According to Business Quant data, Interest & Investment Income came in at $28,000 in FY2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 International Stem Cell 2.40 Mn -1.57 Mn 1.46 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2010 877.00
Sep 30, 2010 1,124.00
Jun 30, 2010 350.00
API Access

International Stem Cell Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ISCO&period=max&api_key=YOUR_API_KEY